Electronic Prescribing - Conformance Test Specifications v3.0.4

This release of the end-product EP-3938:2024 provides the following updates:

DH-3945:2024 Electronic Prescribing – Conformance Test Specifications – General Prescribing Systems v3.0.4 replaces the following product on its effective September 2024:

• DH_3728_2022 Electronic Prescribing – Conformance Test Specifications - Prescribing Systems v3.0.3
• DH-3945:2024Electronic Prescribing – Conformance Test Specifications – General Prescribing Systems v3.0.4 includes the following important updates:
  • Minor changes to wording to align with split Conformance Profile updates

DH-3946:2024 Electronic Prescribing – Conformance Test Specifications - Dispensing Systems v3.0.4 replaces the following product on its effective September 2024:

• DH_3729_2022 Electronic Prescribing – Conformance Test Specifications -Dispensing Systems v3.0.3
• DH-3946:2024 Electronic Prescribing – Conformance Test Specifications - Dispensing Systems v3.0.4 includes the following important updates:
  • Minor changes to wording to align with split Conformance Profile updates

DH-3947:2024 Electronic Prescribing – Conformance Test Specifications – National Prescription Delivery Service v3.0.4 replaces the following product on its effective September 2024:

• DH_3730_2022 Electronic Prescribing – Conformance Test Specifications - Prescription Delivery Services v3.0.3
• DH-3947:2024 Electronic Prescribing – Conformance Test Specifications – National Prescription Delivery Service v3.0.4 includes the following important updates:
  • Minor changes to wording to align with split Conformance Profile updates

DH-3948:2024 Electronic Prescribing – Conformance Test Specifications – Active Script List Registry v3.0.4 replaces the following product on its effective date  September 2024:

• DH_3731_2022 Electronic Prescribing – Conformance Test Specifications - Active Script List Registry v3.0.3
• DH-3948:2024 Electronic Prescribing – Conformance Test Specifications - Active Script List Registry v3.0.4 includes the following important updates:
  • Minor changes to wording to align with split Conformance Profile updates

DH-3949:2024 Electronic Prescribing – Conformance Test Specifications – Mobile Channel v3.0.4 replaces the following product on its effective date September 2024:

• DH_3732_2022 Electronic Prescribing – Conformance Test Specifications - Mobile Channel v3.0.3
• DH-3949:2024 Electronic Prescribing – Conformance Test Specifications - Mobile Channel v3.0.4 includes the following important updates:
  • Minor changes to wording to align with split Conformance Profile updates

DH-3950:2024 Electronic Prescribing – Test Data- Prescribe and Dispense Personas v3.0.4 replaces the following product on its effective September 2024:

• DH_3231_2020 Electronic Prescribing – Test Data- Prescribe and Dispense Personas v2.0
• DH-3950:2024 Electronic Prescribing – Test Data- Prescribe and Dispense Personas v3.0.4 includes the following important updates:
  • Minor changes to wording to align with split Conformance Profile updates